López-Defaz FD, Aguirre-Villegas AS, Constante-Noboa MA. Anticuerpos monoclonales en cáncer de mama triple negativo metastásico: Sacituzumab Govitecan y Pembrolizumab [Monoclonal antibodies in metastatic triple-negative breast cancer: Sacituzumab Govitecan and Pembrolizumab]. CER [Internet]. 2025 Oct. 20 [cited 2026 Jul. 27];3(especial2):102-13. Available from: https://www.revistasinstitutoperspectivasglobales.rperspectivasinvestigativas.org/index.php/CER/article/view/907